Phospho-specific plasma p-tau181 assay detects clinical as well as asymptomatic Alzheimer's disease.
Steffi De MeyerJeroen VanbrabantJolien M SchaeverbekeMariska ReinartzEmma Susanne LuckettPatrick DupontKoen Van LaereErik StoopsEugeen VanmechelenKoen PoesenRik VandenberghePublished in: Annals of clinical and translational neurology (2022)
The novel plasma p-tau181 assay is an accurate tool to detect clinical as well as asymptomatic AD and provides a phospho-specific alternative to currently employed immunoassays.